跳至主要内容
临床试验/ACTRN12617000537358
ACTRN12617000537358已完成3 期

Efficacy of Incontinence Associated Dermatitis Interventions for Critically Ill Patients in Intensive Care: the Distinct Pilot Randomised Control Trial.

Queensland University of Technology0 个研究点目标入组 30 人开始时间: 2017年4月13日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1) >17 years of age
  • 2) Incontinent of urine and/or stool.
  • 3) Predicted ICU length of stay (LOS) of at least 5 days

排除标准

  • 2) Colorectal surgery resulting in a colostomy
  • 3) Current pressure area ulcer/sore where the skin is affected by incontinence.
  • 4) Current community-acquired IAD.
  • 5) Continent of urine and faeces.
  • 6) Have a dermatological disease (e.g. psoriasis, eczema) that is likely to interfere with the evaluation of the patient.
  • 7) Presence of a fungal infection on the study area
  • 8) Are currently enrolled in 3 non-intervention drug or device studies in the ICU research site
  • 9) Currently participating in an investigational drug or device study.
  • 10) The participant has a medical condition that in the opinion of the investigator would exclude him/her from participating in the study.
  • 11) Hypersensitivity to CavilonTM Advanced Skin Protectant or its excipients.

研究者

相似试验

Efficacy of Incontinence Associated Dermatitis... | 临床试验